SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000850261-20-000020
Filing Date
2020-01-24
Accepted
2020-01-23 18:10:42
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 srne424b3finalprospectus.htm 424B3 218159
2 GRAPHIC image1.jpg GRAPHIC 13004
3 GRAPHIC image2.jpg GRAPHIC 13004
  Complete submission text file 0000850261-20-000020.txt   255312
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-234869 | Film No.: 20543250
SIC: 2836 Biological Products, (No Diagnostic Substances)